Found: 132
Select item for more details and to access through your institution.
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2457, doi. 10.1093/rheumatology/keae230
- By:
- Publication type:
- Article
Granulomatous uveitis secondary to IgG4-related disease.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Predictors of disease relapse in IgG4-related disease following rituximab.
- Published in:
- Rheumatology, 2016, v. 55, n. 6, p. 1000, doi. 10.1093/rheumatology/kev438
- By:
- Publication type:
- Article
Methotrexate for maintenance of remission in IgG4-related disease.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.
- Published in:
- Rheumatology, 2015, v. 54, n. 8, p. 1360, doi. 10.1093/rheumatology/keu483
- By:
- Publication type:
- Article
Human Monocytic Ehrlichiosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 18, p. 2263, doi. 10.1001/jama.292.18.2263
- By:
- Publication type:
- Article
Polyarteritis Nodosa.
- Published in:
- JAMA: Journal of the American Medical Association, 2002, v. 288, n. 13, p. 1632, doi. 10.1001/jama.288.13.1632
- By:
- Publication type:
- Article
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. e1130, doi. 10.1093/cid/ciaa1759
- By:
- Publication type:
- Article
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 2, p. 258, doi. 10.1093/mr/roac098
- By:
- Publication type:
- Article
Perspectives on current and emerging therapies for immunoglobulin G4-related disease.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 2, p. 229, doi. 10.1093/mr/roac141
- By:
- Publication type:
- Article
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers.
- Published in:
- Modern Rheumatology, 2017, v. 27, n. 4, p. 638, doi. 10.1080/14397595.2016.1227026
- By:
- Publication type:
- Article
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.
- Published in:
- Rheumatology, 2022, v. 61, n. 7, p. 2915, doi. 10.1093/rheumatology/keab780
- By:
- Publication type:
- Article
association of smoking with immunoglobulin G4–related disease: a case–control study.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5310, doi. 10.1093/rheumatology/keab172
- By:
- Publication type:
- Article
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4929, doi. 10.1093/rheumatology/keab096
- By:
- Publication type:
- Article
IgG4-related disease of the mitral and aortic valves presenting as rapid, recurrent prosthetic valve failure.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
- Published in:
- Rheumatology, 2020, v. 59, n. 9, p. 2308, doi. 10.1093/rheumatology/kez589
- By:
- Publication type:
- Article
272 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the GiACTA trial.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
O26 Effects of baseline prednisone dose on remission and disease flare in patients with giant cell arteritis treated with tocilizumab in the GiACTA trial.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
172. The association of differences in lipid parameters with disease activity in ANCA-associated vasculitis (AAV).
- Published in:
- 2019
- By:
- Publication type:
- Abstract
171. Cardiovascular disease is the most common cause of death in ANCA-associated vasculitis (AAV).
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Why do temporal arteries go wrong? Principles and pearls from a clinician and a pathologist.
- Published in:
- Rheumatology, 2018, v. 57, p. ii3, doi. 10.1093/rheumatology/kex524
- By:
- Publication type:
- Article
Foreword: clinical challenges of diagnosing and managing giant cell arteritis.
- Published in:
- Rheumatology, 2018, v. 57, p. ii1, doi. 10.1093/rheumatology/key003
- By:
- Publication type:
- Article
Treatment approaches in primary Sjogren syndrome.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 18, p. 2015, doi. 10.1001/jama.2010.1582
- By:
- Publication type:
- Article
Treatment of primary Sjögren syndrome: a systematic review.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Treatment of Primary Sjögren Syndrome.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 4, p. 452, doi. 10.1001/jama.2010.1014
- By:
- Publication type:
- Article
Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00853-7
- By:
- Publication type:
- Article
Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial.
- Published in:
- International Journal of Rheumatology, 2015, v. 2015, p. 1, doi. 10.1155/2015/589841
- By:
- Publication type:
- Article
Design of the Tocilizumab in Giant Cell Arteritis Trial.
- Published in:
- International Journal of Rheumatology, 2013, p. 1, doi. 10.1155/2013/912562
- By:
- Publication type:
- Article
IgG4-Related Disease.
- Published in:
- International Journal of Rheumatology, 2013, p. 1, doi. 10.1155/2013/532612
- By:
- Publication type:
- Article
Development of an IgG4-RD Responder Index.
- Published in:
- International Journal of Rheumatology, 2012, p. 1, doi. 10.1155/2012/259408
- By:
- Publication type:
- Article
IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.
- Published in:
- International Journal of Rheumatology, 2012, p. 1, doi. 10.1155/2012/139409
- By:
- Publication type:
- Article
A 44-year-old man with eye, kidney, and brain dysfunction.
- Published in:
- 2016
- By:
- Publication type:
- journal article
IgG4-related disease presenting as recurrent mastoiditis.
- Published in:
- Laryngoscope, 2012, v. 122, n. 3, p. 681, doi. 10.1002/lary.22486
- By:
- Publication type:
- Article
Lymphomas in IgG4-related disease: clinicopathologic features in a Western population.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 1, p. 51, doi. 10.1002/acr2.11520
- By:
- Publication type:
- Article
Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 4, p. 371, doi. 10.1002/acr2.11405
- By:
- Publication type:
- Article
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 2, p. 168, doi. 10.1002/acr2.11366
- By:
- Publication type:
- Article
Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End‐Stage Renal Disease in the US Renal Data System.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 1, p. 8, doi. 10.1002/acr2.11359
- By:
- Publication type:
- Article
Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 12, p. 834, doi. 10.1002/acr2.11340
- By:
- Publication type:
- Article
Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis.
- Published in:
- ACR Open Rheumatology, 2020, v. 2, n. 5, p. 261, doi. 10.1002/acr2.11133
- By:
- Publication type:
- Article
Comparative Effectiveness of Rituximab‐ Versus Cyclophosphamide‐Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis for the Risk of Kidney Failure and Mortality.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1599, doi. 10.1002/art.42515
- By:
- Publication type:
- Article
Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 748, doi. 10.1002/art.42418
- By:
- Publication type:
- Article
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 736, doi. 10.1002/art.42388
- By:
- Publication type:
- Article
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A<sub>1c</sub> During the Treatment of Giant Cell Arteritis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 4, p. 586, doi. 10.1002/art.42405
- By:
- Publication type:
- Article
Expert Perspective: Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 8, p. 1305, doi. 10.1002/art.42114
- By:
- Publication type:
- Article
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1366, doi. 10.1002/art.41773
- By:
- Publication type:
- Article
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1384, doi. 10.1002/art.41776
- By:
- Publication type:
- Article
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1349, doi. 10.1002/art.41774
- By:
- Publication type:
- Article
Disease Severity Linked to Increase in Autoantibody Diversity in IgG4‐Related Disease.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 4, p. 687, doi. 10.1002/art.41140
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor